Target intelligence / Profile preview

Acetyl-CoA acetyltransferase 2 (ACAT2)

Target
ACAT2
Molecular classification
Enzyme, Transferase, Acyltransferase, Member of the thiolase family
01

Overview

Acetyl-CoA acetyltransferase 2 (ACAT2) is a cytosolic enzyme primarily involved in the metabolism of lipids and the biosynthesis of cholesterol and ketone bodies[1][3][8]. It catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA, acting as a thiolase in key metabolic pathways such as fatty acid metabolism, cholesterol synthesis, and ketone body metabolism. ACAT2 is encoded by the ACAT2 gene on human chromosome 6. Dysfunction of this enzyme is associated with rare inherited metabolic disorders and may have a role in broader lipid homeostasis[1][8].

Other names
Cytosolic acetoacetyl-CoA thiolaseAcetyl-Coenzyme A acetyltransferase 2Thiolase II
02

Mechanism of action

Inhibitors of ACAT2 would block the conversion of acetyl-CoA to acetoacetyl-CoA, thereby affecting cholesterol and lipid biosynthesis

03

Biological functions

Lipid metabolismCholesterol biosynthesisKetone body metabolismFatty acid metabolismEnergy production
04

Disease associations

Metabolic disorders (e.g., Alpha-Methylacetoacetic Aciduria, Acetyl-CoA Acetyltransferase-2 deficiency)Disorders of ketone body transportPossibly implicated in lipid metabolism disorders
05

Safety considerations

Targeting ACAT2 could alter cholesterol and lipid homeostasis, potentially leading to hepatic or systemic metabolic side effectsInhibiting ACAT2 might theoretically cause accumulation or depletion of acetoacetyl-CoA, affecting energy production
06

Interacting drugs

Sulfasalazine [as an inhibitor, but mainly for ACAT1; possible cross-reactivity not ruled out]

1 more in the full profile.

07

Biomarkers

ACAT2 messenger RNA or protein levels could theoretically serve as biomarkers in disorders of cholesterol or lipid metabolism, but no established clinical biomarkers are referenced in major databases

Beyond the preview

Go deeper on Acetyl-CoA acetyltransferase 2 (ACAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetyl-CoA acetyltransferase 2 (ACAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call